Sweden approves Vectura's AirFluSal inhaler
14th Jan 2014 13:03
Vectura, the AIM-listed respiratory development company, confirmed that its partner Sandoz, has received Swedish marketing authorisation for AirFluSal Forspiro, a new inhaler for patients with asthma and chronic obstructive pulmonary disease. The firm, which focuses on the development of pharmaceut
Read moreThursday broker round-up UPDATE
19th Dec 2013 08:27
AstraZeneca: Alphavalue lowers target price from 3169p to 3087.7p and downgrades from reduce to sell. British American Tabacco: Panmure Gordon reduces target price from 3800p to 3200p and downgrades from buy to hold. Britvic: Investec ups target price from 600p to 672p and maintains a hold recomme
Read moreGlaxo COPD approval cooled by generic Advair competition
19th Dec 2013 07:58
US regulators have approved GlaxoSmithKline's treatment for chronic obstructive pulmonary disease, but the excitement was cooled by news that Denmark has approved the sale of a generic copy of GSK's biggest product, Advair. On Wednesday evening Glaxo and Theravance announced that the US Food and Dr
Read moreTuesday broker round-up UPDATE
24th Sep 2013 08:31
African Barrick Gold: Liberum Capital upgrades to hold with a target price of 147p. Amec: UBS reduces target price from 1200p to 1145p downgrading from buy to neutral. Compass Group: Investec ups target price from 900p to 925p and keeps a buy recommendation. CVS Group: Investec takes target price
Read moreFriday broker round-up UPDATE
20th Sep 2013 08:06
African Minerals: Investec reduces target price from 393p to 246p, while its buy recommendation remains unchanged. Ashmore Group: Berenberg cuts target price from 500p to 470p and retains a buy recommendation. ASOS: Deutsche Bank raises target price from 4450p to 4800p and reiterates a hold recomm
Read moreThursday broker round-up UPDATE
5th Sep 2013 08:03
AMEC: Nomura reduces target price from 1300p to 1230p, while reiterating its buy recommendation. Antofagasta: Exane cuts target price from 1200p to 1100p maintaining an outperform rating. Ashtead Group: JP Morgan shifts target price from 729p to 734p and keeps a neutral rating. Associated British
Read moreVectura gains European CHMP endorsement for Ultibro
26th Jul 2013 16:20
Respiratory drug developer Vectura has received positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for its new inhaled pulmonary treatment being tested by Novartis. The FTSE Small Cap company reported that the European Medicines Agency's CHMP gave its positive opinion
Read moreThursday broker round-up UPDATE
4th Jul 2013 08:17
Aberdeen Asset Management: JP Morgan reduces target price from 573p to 476p and reiterates its overweight rating. Ashmore Group: JP Morgan cuts target price from 410p to 339p maintaining a neutral rating. ASOS: Jefferies raises target price from 2199p to 6200p and upgrades from underperform to buy
Read moreThursday broker round-up UPDATE
20th Jun 2013 08:43
Ashtead Group: Jefferies takes target price from 690p to 750p and leaves its buy recommendation unchanged. ASOS: Deutsche Bank increases target price from 3300p to 3800p and reiterates a hold recommendation. Atkins: Liberum Capital takes target price from 1020p to 1100p and maintains a buy recomme
Read moreMonday broker round-up UPDATE
10th Jun 2013 07:34
ASOS: HSBC Holdings increases target price from 3660p to 4380p and keeps an overweight rating. Bellway: Deutsche Bank raises target price from 1482p to 1503p and reiterates a hold recommendation. Betfair Group: Citi ups target price from 880p to 950p, upgrading from neutral to buy. Capco: UBS inc
Read moreWednesday broker round-up UPDATE
22nd May 2013 09:37
Afferro Mining: Panmure Gordon reduces target price from 279p to 100p, while keeping its buy recommendation. Amara Mining: Westhouse Securities cuts target price from 110p to 90p retaining a buy recommendation. Amlin: Westhouse Securities moves target price from 455p to 470p and upgrades to add.
Read moreMonday broker round-up UPDATE
17th Dec 2012 07:21
Aggreko: Panmure Gordon reduces target price from 2159p to 1935p, while keeping a hold recommendation. Investec downgrades to hold. Amara Mining: Investec starts with a target price of 89p and a buy rating. ASOS: Goldman Sachs increases target price from 3200p to 3600p and recommends a strong buy.
Read moreFriday broker round-up UPDATE
30th Nov 2012 07:24
Aggreko: Berenberg initiates with a target price of 2010p and a hold recommendation. APR Energy: Berenberg starts with a target price of 610p and a sell recommendation. Babcock International Group: Berenberg initiates with a target price of 1180p and a buy recommendation. Barclays: UBS raises tar
Read moreTuesday broker round-up - UPDATE
13th Nov 2012 07:11
Aveva Group: UBS raises target price from 1740p to 1810p and downgrades from neutral to sell. Balfour Beatty: Berenberg downgrades from buy to hold. Bovis Homes Group: Deutsche Bank raises target price from 578p to 599p and maintains buy rating. BTG: Deutsche Bank raises target price from 394p to
Read moreVectura director exercises options after milestone payment
28th Sep 2012 17:17
Shares of Cambridge-based Vectura rose after it confirmed the Japanese government has approved its Seebri inhalation capsules used in inhaler devices. The shares rose 2p to 86.5p, on news that government clearance will trigger a £2.5m milestone payment for Vectura from its partner Novartis. Whethe
Read more